Open AccessOral candidiasis as a consequence of the systemic disease or its drug therapy
Author(s) -
Irina K. Lutskaya,
AUTHOR_ID
Publication year - 2021
Publication title -
kliničeskij razbor v obŝej medicine
Language(s) - English
Resource type - Journals
eISSN - 2782-5671
pISSN - 2713-2552
DOI - 10.47407/kr2021.2.8.00092
Subject(s) - medicine , systemic candidiasis , systemic therapy , intensive care medicine , drug , oral mucosa , dermatology , disease , systemic disease , systemic antibiotics , flora (microbiology) , antifungal , pharmacology , antibiotics , pathology , biology , genetics , corpus albicans , cancer , breast cancer , bacteria , microbiology and biotechnology
The emergence, development and treatment of systemic diseases could go along with activation of saprophytic fungal flora, including in the oral mucosa. In such cases, the patients complain of discomfort and soreness in response to irritants. Local treatment is used for mild forms. Generalized candidiasis requires prescribing systemic therapy, which is provided by the general practitioner (primary care physician). The dentist provides topical treatment.